STRO
Sutro Biopharma, Inc.Healthcare$23.78
▼ Bearish
Mkt Cap: $394.0M|Float: 15.2M|SI: 3.5%|DTC: 3.7
Data as of market close Apr 2, 2026
IV Rank
81
IV Pctl
56%
HV 20d
7339.0%
52W Range
$5-$27
ATR(14)
$2.07
Exp. Move
±10.9%
P/C Ratio
11.46
Earnings
-
GEX Negative
DEX Long
Net Call Premium
IV High
Max Pain Below
Exp. Move Wide
High Put/Call
STRO Key Options Data
- IV Rank
- 80.8%
- Total GEX
- $-0.00B
- Total DEX
- $0.0M
- Max Pain
- $22.50
- Expected Move
- ±10.9%
- Put/Call OI
- 11.46
- Net Premium
- $0.0M
- Spot Price
- $23.78
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$2.60 | ±10.9% | $21.18 | $26.38 |
| 2026-05-15 | 43 | ±$3.75 | ±15.8% | $20.03 | $27.53 |
| 2026-08-21 | 141 | ±$14.00 | ±58.9% | $9.78 | $37.78 |
Explore STRO options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.